InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: spiritthing post# 81855

Friday, 03/16/2018 3:07:18 PM

Friday, March 16, 2018 3:07:18 PM

Post# of 144814

Yes, exactly! ...keeping their cards close to their chest.

Just like all biotechs do.

It’s what they’ve always done and will continue to do....a common strategy.

To the new investors here, and contrary to what you may have heard, PharmaCyte, their ongoing CiaB therapy development, and their consortium of world renowned scientist and doctors are not a scam.
http://pharmacyte.com/company/pharmacyte-biotech-advisory-board/
Regarding the members of the consortium, there has been no indication or notices to any of their departures to date. There is absolutely no proof otherwise. None.

In fact, the progressing development of CiaB’s therapy could not be possible without their ongoing support and participation.

No, PharmaCyte’s CiaB therapy development is not a scam and the recent announcement of the MCB progress proves the legitimacy of the project developing.

As far as Yuen goes, if Austrianova is successful, then having him on board certainly adds to the potential of getting funded for the trial...among other possibilities, depending on Yuen’s interest, of course. :) :) :)

As a confident long I will continue to be patient and understand that there are time consuming complexities....complexities some here continue to misinterpret....complexities that make it difficult to meet the scheduling or predictions of any biotech CEO.

At the end of the day, I for one believe KW is doing a decent job at getting the CiaB therapy developed.

Nevertheless, we’ll soon be getting the news of encapsulation. If it is positive the IND is sure to follow.

Then, as efood puts it....KABOOM!!!


Go PharmaCyte!!!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News